Investigation summary: sample evaluation: n/a.Bhr review we have reviewed our production and inspection records and have established that all production and quality processes were carried out normally.Neither qn nor ncmr's.Syringes were packed in machine (b)(4) (july 6 - 8th, 2017).Syringes were assembled in machine (b)(4), in lot #7187063, #7083155, #7076204, and 7160167.Research has found no problems, defects or qn related to the reported issue.We have also reviewed the barrel lots #7187033, #7160140, #77083124, #7055064, #7062452, #7076180, #7072489, and #7062452, and no problems, defects or qn related to the reported issue were found.Investigation conclusion: root cause analysis: the material used to manufacture emerald syringes has been selected and tested to resist normal conditions of use.The assembling machines have an on-line detection system that inspects 100 % the syringes, rejecting automatically the syringes with damaged parts like the tip of the barrel.Based on this fact, we think that the syringe tip could broke caused by some inappropriate handling condition or transport of the product before use.Confirmation: no picture or sample returned for evaluation.No issues found in the bhr review.We could not confirm the reported issue.Capa determination: no - based on an evaluation of severity and occurrence it was determinate that no corrective action is required at this time.
|